ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma. Wu Y, Mu G, Li F, Sun Y, et al. PLoS One 2024;19:e0314618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu Y, Mu G, Li F, Sun Y, et al. ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma. PLoS One 2024;19:e0314618.
PMID: 39621695